{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:05:28Z","timestamp":1780394728701,"version":"3.54.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["CRG\/2019\/001389"],"award-info":[{"award-number":["CRG\/2019\/001389"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jbc.2025.110753","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:33:08Z","timestamp":1758619988000},"page":"110753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["G-Quadruplex\u2013specific action of chloroquine-based immunomodulator drugs to inhibit the cancer progression"],"prefix":"10.1016","volume":"301","author":[{"given":"Sunipa","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhojit","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Bisoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosenjit","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Chandra Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110753_bib1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/cancers14030627","article-title":"Chemotherapy side-effects: not all DNA damage is equal","volume":"14","author":"van den Boogaard","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jbc.2025.110753_bib2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1126\/science.3945817","article-title":"A turning point in cancer research: sequencing the human genome","volume":"231","author":"Dulbecco","year":"1986","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jbc.2025.110753_bib3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2741\/4555","article-title":"Base excision repair of oxidative DNA damage: from mechanism to disease","volume":"22","author":"Whitaker","year":"2017","journal-title":"Front. Biosci. (Landmark Edition)"},{"key":"10.1016\/j.jbc.2025.110753_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110753_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","article-title":"Transcriptional amplification in tumor cells with elevated c-Myc","volume":"151","author":"Lin","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110753_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fcell.2017.00010","article-title":"Strategies to inhibit myc and their clinical applicability","volume":"5","author":"Whitfield","year":"2017","journal-title":"Front. Cell. Dev. Biol"},{"key":"10.1016\/j.jbc.2025.110753_bib7","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1093\/nar\/gkz835","article-title":"New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription","volume":"47","author":"Hu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.110753_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd3428","article-title":"Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?","volume":"10","author":"Balasubramanian","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2025.110753_bib9","doi-asserted-by":"crossref","first-page":"11593","DOI":"10.1073\/pnas.182256799","article-title":"Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription","volume":"99","author":"Siddiqui-Jain","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110753_bib10","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1039\/C3CC48390H","article-title":"Targeting a c-MYC G-quadruplex DNA with a fragment library","volume":"50","author":"Nasiri","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jbc.2025.110753_bib11","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1093\/nar\/gky187","article-title":"G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy","volume":"46","author":"Ruggiero","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.110753_bib12","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1093\/nar\/gkz463","article-title":"Thermodynamically stable and genetically unstable G-quadruplexes are depleted in genomes across species","volume":"47","author":"Puig Lombardi","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.110753_bib13","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1093\/nar\/gki609","article-title":"Prevalence of quadruplexes in the human genome","volume":"33","author":"Huppert","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.110753_bib14","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.1021\/ja050823u","article-title":"Putative DNA quadruplex formation within the human c-kit oncogene","volume":"127","author":"Rankin","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2025.110753_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkz1097","article-title":"A guide to computational methods for G-quadruplex prediction","volume":"48","author":"Puig Lombardi","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.110753_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-021-01328-4","article-title":"G-quadruplexes: a promising target for cancer therapy","volume":"20","author":"Kosiol","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2025.110753_bib17","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1093\/nar\/gki553","article-title":"Highly prevalent putative quadruplex sequence motifs in human DNA","volume":"33","author":"Todd","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.110753_bib18","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.molmed.2020.05.002","article-title":"G-Quadruplex, friend or foe: the role of the G-quartet in anticancer strategies","volume":"26","author":"Carvalho","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jbc.2025.110753_bib19","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1093\/nar\/gkv862","article-title":"G-quadruplexes and their regulatory roles in biology","volume":"43","author":"Rhodes","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.110753_bib20","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1039\/D2CC06347F","article-title":"Downregulation of gene expression in hypoxic cancer cells by an activatable G-quadruplex stabiliser","volume":"59","author":"Uyar","year":"2023","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jbc.2025.110753_bib21","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1021\/ja017308q","article-title":"Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex","volume":"124","author":"Kim","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2025.110753_bib22","first-page":"639","article-title":"Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells","volume":"59","author":"Izbicka","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.110753_bib23","doi-asserted-by":"crossref","first-page":"15758","DOI":"10.1021\/ja805615w","article-title":"A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres","volume":"130","author":"Rodriguez","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2025.110753_bib24","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/cells8101274","article-title":"The oncogenic signaling pathways in BRAF-mutant melanoma cells are modulated by naphthalene diimide-like G-quadruplex ligands","volume":"8","author":"Recagni","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2025.110753_bib25","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1158\/0008-5472.CAN-04-2910","article-title":"The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function","volume":"65","author":"Burger","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.110753_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/acs.accounts.2c00757","article-title":"Template-assembled synthetic G-quartets (TASQs): multiTASQing molecular tools for investigating DNA and RNA G-quadruplex biology","volume":"56","author":"Monchaud","year":"2023","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jbc.2025.110753_bib27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40261-018-0656-y","article-title":"Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review","volume":"38","author":"Plantone","year":"2018","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jbc.2025.110753_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5114\/reum.2018.76904","article-title":"Antimalarials - are they effective and safe in rheumatic diseases?","volume":"56","author":"Ha\u0142adyj","year":"2018","journal-title":"Reumatologia"},{"key":"10.1016\/j.jbc.2025.110753_bib29","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/jac\/dkv018","article-title":"Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases","volume":"70","author":"Al-Bari","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jbc.2025.110753_bib30","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1182\/blood.V124.21.5775.5775","article-title":"A phase II trial of chloroquine in combination with bortezomib and cyclophosphamide in patients with relapsed and refractory multiple myeloma","volume":"124","author":"Montanari","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.110753_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/futurepharmacol2040028","article-title":"A critical review of chloroquine and hydroxychloroquine as potential adjuvant agents for treating people with cancer","volume":"2","author":"Abdel-Aziz","year":"2022","journal-title":"Future Pharmacol."},{"key":"10.1016\/j.jbc.2025.110753_bib32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3332\/ecancer.2017.781","article-title":"Repurposing drugs in oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents","volume":"11","author":"Verbaanderd","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.jbc.2025.110753_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11864-023-01053-8","article-title":"Autophagy paradox: strategizing treatment modality in melanoma","volume":"24","author":"Pangilinan","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.jbc.2025.110753_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41419-020-03324-w","article-title":"Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response","volume":"12","author":"Tian","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jbc.2025.110753_bib35","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3892\/mmr.2014.2839","article-title":"Chloroquine inhibits MGC803 gastric cancer cell migration via the Toll-like receptor 9\/nuclear factor kappa B signaling pathway","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jbc.2025.110753_bib36","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3892\/ol.2013.1602","article-title":"Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer","volume":"6","author":"Tuomela","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jbc.2025.110753_bib37","article-title":"Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.110753_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251731","article-title":"Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy","volume":"16","author":"Krueger","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.110753_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101990","article-title":"Hydroxychloroquine can impair tumor response to anti-PD1 in subcutaneous mouse models","volume":"24","author":"Wabitsch","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jbc.2025.110753_bib40","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1021\/acs.jpcb.2c03267","article-title":"Spectroscopic and molecular dynamics aspect of antimalarial drug hydroxychloroquine binding with human telomeric G-quadruplex","volume":"126","author":"Sarkar","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jbc.2025.110753_bib41","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/biomedicines11030969","article-title":"G-quadruplexes in c-MYC promoter as targets for cancer therapy","volume":"11","author":"Bahls","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbc.2025.110753_bib42","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/bi048242p","article-title":"Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization","volume":"44","author":"Ambrus","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2025.110753_bib43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchem.1548","article-title":"Quantitative visualization of DNA G-quadruplex structures in human cells","volume":"5","author":"Biffi","year":"2013","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jbc.2025.110753_bib44","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1038\/s41467-018-06315-w","article-title":"Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex","volume":"9","author":"Calabrese","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110753_bib45","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2320240121","article-title":"G-quadruplex DNA structure is a positive regulator of MYC transcription","volume":"121","author":"Esain-Garcia","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110753_bib46","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1101\/gad.1024602","article-title":"c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression","volume":"16","author":"Baudino","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2025.110753_bib47","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","article-title":"Regulation of cancer cell metabolism: oncogenic MYC in the driver\u2019s seat","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transd. Target. Ther."},{"key":"10.1016\/j.jbc.2025.110753_bib48","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1158\/0008-5472.CAN-10-3776","article-title":"MYC and metastasis","volume":"71","author":"Wolfer","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.110753_bib49","doi-asserted-by":"crossref","first-page":"17673","DOI":"10.1021\/ja205646q","article-title":"Solution structure of a 2:1 quindoline-c-MYC G-quadruplex: insights into G-quadruplex-interactive small molecule drug design","volume":"133","author":"Dai","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2025.110753_bib50","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1634\/theoncologist.2014-0086","article-title":"Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma","volume":"19","author":"Wolpin","year":"2014","journal-title":"The oncologist"},{"key":"10.1016\/j.jbc.2025.110753_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41523-025-00722-1","article-title":"Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+\/HER2\u2212 breast cancer","volume":"11","author":"Raghavendra","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.jbc.2025.110753_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jbc.2025.110753_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205584","article-title":"Crystal structure of the major quadruplex formed in the promoter region of the human c-MYC oncogene","volume":"13","author":"Stump","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.110753_bib54","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1021\/acs.jctc.6b00186","article-title":"Assessing the current state of amber force field modifications for DNA","volume":"12","author":"Galindo-Murillo","year":"2016","journal-title":"J. Chem. Theor. Comput"},{"key":"10.1016\/j.jbc.2025.110753_bib55","doi-asserted-by":"crossref","first-page":"21231","DOI":"10.1021\/acsomega.0c03091","article-title":"Effect of hydration on the molecular dynamics of hydroxychloroquine sulfate","volume":"5","author":"Mamontov","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.jbc.2025.110753_bib56","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jbc.2025.110753_bib57","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J. Phys. Chem. A."},{"key":"10.1016\/j.jbc.2025.110753_bib58","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"Gromacs 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theor. Comput"},{"key":"10.1016\/j.jbc.2025.110753_bib59","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jbc.2025.110753_bib60","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1021\/j100308a038","article-title":"The missing term in effective pair potentials","volume":"91","author":"Berendsen","year":"1987","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jbc.2025.110753_bib61","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.jbc.2025.110753_bib62","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jbc.2025.110753_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825026055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825026055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:57:39Z","timestamp":1773190659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825026055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0021925825026055"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110753","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"G-Quadruplex\u2013specific action of chloroquine-based immunomodulator drugs to inhibit the cancer progression","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110753"}}